(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE
Compound with spectra: 1 NMR
![(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE](/api/compound/1Snv4nM1z4u.png?ph=true&h=300&w=458 "(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-FLUOROPHENYL)-3-OXABICYCLO-[3.1.0]-HEXANE")
| SpectraBase Compound ID | 1Snv4nM1z4u |
|---|---|
| InChI | InChI=1S/C13H13FO2/c1-2-11-9-7-13(9,12(15)16-11)8-5-3-4-6-10(8)14/h3-6,9,11H,2,7H2,1H3/t9-,11-,13+/m0/s1 |
| InChIKey | UCJQVQOJMILTQP-XHVZSJERSA-N |
| Mol Weight | 220.24 g/mol |
| Molecular Formula | C13H13FO2 |
| Exact Mass | 220.089958 g/mol |
| Enantiomer InChIKey | UCJQVQOJMILTQP-XWIASGKRSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,4S,5R)-2-OXO-4-ETHYL-1-(2-NAPHTHYL)-3-OXABICYCLO-[3.1.0]-HEXANE
(1S,2R)-1-(2-FLUOROPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
(1S,2R)-1-(2-METHYLPHENYL)-2-[(S)-1-AMINOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE-HYDROCHLORIDE
o-[1-CARBOXY-1-(2-HYDROXYPROPYL)-3-BUTENYL]BENZOIC ACID, gamma-LACTONE, METHYL ESTER
1-Methoxycarbonyl-benzo-bicyclo(2.2.1)hepta-2,5-diene
(3Aa, 9ba)-2,3,3a,4,5,9b-hexahydro-1H-benz(E)indene-9b-carboxylic acid, methyl ester
6,10,10-Trimethyl-1-phenyl-3,11-dioxabicyclo[7.2.0]undecan-2-one
1,3-Dimethyl-3-((tetrahydro-2H-thiopyran-2-yl)methyl)indolin-2-one
(+)-(2R,3R,1'R,2'S,5'R)-1,1-DIFLUORO-2-(4-METHOXYPHENYLAMINO)-3-(8'-PHENYLMENTHYLOXYCARBONYL)-CYCLOPENTANE
(+)-(2S,3S,1'R,2'S,5'R)-1,1-DIFLUORO-2-(4-METHOXYPHENYLAMINO)-3-(8'-PHENYLMENTHYLOXYCARBONYL)-CYCLOPENTANE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |